A Study of Patients With HER2-Positive Metastatic Breast Cancer

registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00105456

Enrollment

1000

Registered

2005-03-15

Start date

2003-03-31

Completion date

2009-05-31

Last updated

2010-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

HER2-Positive Metastatic Breast Cancer, HER2

Brief summary

This is a prospective observational cohort study designed to describe effectiveness and safety (treatment outcomes and clinically significant cardiac adverse events, respectively) in patients with HER2-positive metastatic breast cancer.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Signed Informed Consent document (unless the IRB has granted a waiver of consent) * Signed Authorization for the Use and Disclosure of Health Information document * HER2-positive breast cancer * Initial diagnosis of metastatic (Stage IV) breast cancer within 6 months prior to enrollment * Availability of cancer-specific historical data points in the patient's medical records

Exclusion criteria

* There are no

Outcome results